Home > Boards > US Listed > Medical - Drugs > Abbvie (ABBV)

FDA approves ABBV’s Skyrizi (risankizumab) for psoriasis:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 722
Posts 109,310
Boards Moderated 13
Alias Born 09/05/02
160x600 placeholder
Form 8.3 - [Allergan plc] Dow Jones News - 10/17/2019 10:36:00 AM
Form 8.3 - [Allergan plc] Dow Jones News - 10/16/2019 10:22:00 AM
Health-Care Stocks Get a Welcome Respite -- Update Dow Jones News - 10/15/2019 7:58:00 PM
Health-Care Stocks Get a Welcome Respite Dow Jones News - 10/15/2019 12:56:00 PM
Elizabeth Warren's Rise Is Battering Health-Care Stocks Dow Jones News - 10/15/2019 10:22:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 10/15/2019 9:42:00 AM
Elizabeth Warren's Rise Is Battering Health-Care Stocks Dow Jones News - 10/15/2019 8:29:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 10/14/2019 9:11:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 10/11/2019 8:57:00 AM
Reata Pharmaceuticals Shares Up 8% on Re-Acquiring Bardoxolone Rights Dow Jones News - 10/10/2019 12:41:00 PM
Form 8.3 - Allergan Plc Dow Jones News - 10/10/2019 8:35:00 AM
Reata Pharmaceuticals Reacquires Rights to Bardoxolne Dow Jones News - 10/10/2019 7:49:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 10/9/2019 9:02:00 AM
AbbVie Announces New Data from its Dermatology Portfolio and Pipeline at the 28th European Academy of Dermatology and Venereo... PR Newswire (US) - 10/9/2019 2:01:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 10/8/2019 8:46:00 AM
AbbVie to Host Third-Quarter 2019 Earnings Conference Call PR Newswire (US) - 10/8/2019 8:30:00 AM
Form 8.3 -Allergan Plc Dow Jones News - 10/7/2019 10:40:00 AM
Form 8.3 - [Allergan plc] Dow Jones News - 10/4/2019 9:23:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 10/3/2019 9:52:00 AM
Form 8.3 - Allergan Plc Dow Jones News - 10/2/2019 9:20:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 5:56:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 5:53:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 5:51:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 5:49:34 PM
Form 8.3 - [Allergan Plc] Dow Jones News - 10/1/2019 10:52:00 AM
DewDiligence Member Level  Tuesday, 04/23/19 08:00:15 PM
Re: None
Post # of 503 
FDA approves ABBV’s Skyrizi (risankizumab) for psoriasis:

https://finance.yahoo.com/news/abbvie-expands-immunology-portfolio-u-221900007.html

Skyrizi, an IL-23 antagonist, is one of the drugs ABBV is counting on to compensate for lost sales when Humira biosimilars are launched in the US.

Skyrizi is jointly owned by ABBV and B-I. It has received approval in the EU (CHMP recommendation) and Japan.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist